May 2, 2023 10:41 AM EDTUpdated 02:09 PM
News Briefing

New Jer­sey biotech plans for tiny IPO; Vir gets $10M Gates Foun­da­tion grant for HIV vac­cine

Lei Lei Wu

News Reporter

Kyle LaHucik

Senior Reporter

Chro­mo­cell Ther­a­peu­tics, based in North Brunswick, New Jer­sey, plans to go pub­lic, ac­cord­ing to an SEC fil­ing.

Ac­cord­ing to its LinkedIn …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

Mer­ck KGaA to buy rare can­cer biotech Spring­Works for $3.9B

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times